A multicenter, open‐label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non‐small cell lung cancer

Abstract Background Although the incidence of lung cancer in elderly individuals has been increasing in recent years, the number of clinical trials designed specifically for elderly patients with advanced non‐small cell lung cancer (NSCLC) is still limited. To fulfill this unmet medical need, we con...

詳細記述

書誌詳細

出版年:	Thoracic Cancer
主要な著者:	Yohei Yabuki, Masaki Hanibuchi, Eiji Takeuchi, Takashi Haku, Takanori Kanematsu, Naoki Nishimura, Yuko Toyoda, Atsushi Mitsuhashi, Kenji Otsuka, Seidai Sato, Hisatsugu Goto, Hiroto Yoneda, Hirokazu Ogino, Hiroshi Nokihara, Shinohara Tsutomu, Yasuhiko Nishioka
フォーマット:	論文
言語:	英語
出版事項:	Wiley 2023-11-01
主題:	bevacizumab elderly patients pemetrexed previously untreated nonsquamous non‐small cell lung cancer
オンライン･アクセス:	https://doi.org/10.1111/1759-7714.15115